Guidelines for treatment of HIV infected adults in Europe
Resistance testing before initiation of antiretroviral therapy
Newly diagnosed treatment naïve HIV-positive individuals
from the HIV-CAUSAL Collaboration (Canadian and European
cohorts) were included in a study comparing two different
strategies: Testing for transmitted drug resistance (TDR)
within 3 months of baseline versus no TDR testing.
EACS Guidelines
Magazine